InvestSMART

BPH Global Ltd (ASX:BP8)

ALERT: Price-sensitive ASX Announcement for BP8
Current share price for BP8 : $0.002 0 (0%)+
Release
5 Nov 2025 9:47AM
Price at Release
$0.002
Full Release
download
Summary
BPH Global Ltd (ASX: BP8) has entered into an Exclusive Dealing Agreement with Denmark-based scientist Jo-an Refugio to evaluate a proprietary ginseng-based formulation targeted at male vitality and performance. The agreement grants BP8 a six-month exclusive period for due diligence and product testing, during which they may negotiate the acquisition of intellectual property rights. The formulation aligns with BPH Global's R&D focus on Traditional Chinese Medicine-based natural formulations. An exclusivity fee of AUD 9,000 is payable to Jo-an, and further development discussions include the potential engagement of Jo-an as an R&D consultant. The initiative forms part of BPH Global's strategy to develop both OTC wellness products and evidence-based clinically tested products.
Key Points
  • BPH Global Ltd (ASX: BP8) entered an exclusive dealing agreement with scientist Jo-an Refugio.
  • The agreement focuses on a ginseng-based formulation for male vitality and performance.
  • BP8 has a six-month exclusive period for due diligence and product testing.
  • The agreement allows BP8 to negotiate for acquisition of intellectual property rights.
  • A non-refundable exclusivity fee of AUD 9,000 is payable to Jo-an.
  • The formulation is based on Traditional Chinese Medicine principles.
  • The product aims to support male vitality through healthy circulation and energy balance.
  • BPH Global is exploring both OTC wellness products and clinically tested evidence-based products.
  • Further product development may include Jo-an as an R&D consultant.
  • The announcement was authorized by the Board of Directors of BPH Global Ltd.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.